{"id":"https://openalex.org/A5108264141","orcid":"https://orcid.org/0009-0001-1632-5315","observed_orcids":["https://orcid.org/0009-0001-1632-5315"],"display_name":"Mika Kawano","raw_author_names":["Mika Kawano"],"full_name":"Kawano, Mika","works_count":10,"cited_by_count":63,"summary_stats":{"2yr_mean_citedness":3.1666666666666665,"h_index":4,"i10_index":3},"ids":{"openalex":"https://openalex.org/A5108264141","orcid":"https://orcid.org/0009-0001-1632-5315","observed_orcids":["https://orcid.org/0009-0001-1632-5315"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210136522","ror":"https://ror.org/03kjjhe36","display_name":"Tokyo Women's Medical University","country_code":"JP","type":"education","lineage":["https://openalex.org/I4210136522"]},"years":[2019]},{"institution":{"id":"https://openalex.org/I4405254473","ror":"https://ror.org/01v743b94","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},"years":[2026,2025,2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4405254473","ror":"https://ror.org/01v743b94","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","count":6,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","count":6,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","count":5,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","count":2,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","count":2,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","value":6.51e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","value":5.46e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":2.35e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","value":2.09e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","value":1.08e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9675198793411255},{"id":"2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","score":0.6766999959945679},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6035286784172058},{"id":"1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","score":0.5788048505783081},{"id":"159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","score":0.05927345156669617}],"counts_by_year":[{"year":2019,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2023,"works_count":2,"oa_works_count":2,"cited_by_count":3},{"year":2024,"works_count":2,"oa_works_count":2,"cited_by_count":9},{"year":2025,"works_count":3,"oa_works_count":3,"cited_by_count":25},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":26}],"display_name_alternatives":["Mika Kawano"],"block_key":"m kawano","works_api_url":"https://api.openalex.org/works?filter=author.id:A5108264141","updated_date":"2026-11-04T11:47:51","created_date":"2019-06-07T00:00:00"}